Iacobino A, Fattorini L, Giannoni F. Drug-resistant tuberculosis 2020: where we stand. Appl Sci. 2020;10(6):2153.

Article  CAS  Google Scholar 

Asgedom SW, Teweldemedhin M, Gebreyesus H. Prevalence of multidrug-resistant tuberculosis and associated factors in Ethiopia: a systematic review. J Pathogens. 2018;2018:7104921.

Article  Google Scholar 

Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment. Respirology. 2018;23(7):656–73.

Article  PubMed  Google Scholar 

Mazurek GH. Division of tuberculosis elimination, national center for HIV, STD, and TB prevention, centers for disease control and prevention (CDC). Guidelines for using the QuantiFERON-TB gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep. 2005;54:49–55.

PubMed  Google Scholar 

Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022.

Baya B, Achenbach CJ, Kone B, Toloba Y, Dabitao DK, Diarra B, et al. Clinical risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in Mali. IJID. 2019;81:149–55.

PubMed  Google Scholar 

Xi Y, Zhang W, Qiao R-J, Tang J. Risk factors for multidrug-resistant tuberculosis: a worldwide systematic review and meta-analysis. PLoS ONE. 2022;17(6): e0270003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller LG, Asch SM, Yu EI, Knowles L, Gelberg L, Davidson P. A population-based survey of tuberculosis symptoms: how atypical are atypical presentations? Clin Infect Dis. 2000;30(2):293–9.

Article  CAS  PubMed  Google Scholar 

Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J. The diagnosis and treatment of tuberculosis. DÄ International. 2019;116(43)

Hsu D, Irfan M, Jabeen K, Iqbal N, Hasan R, Migliori GB, et al. Post tuberculosis treatment infectious complications. IJID. 2020;92:S41–5.

Google Scholar 

Wang W, Wang J, Zhao Q, Darling ND, Yu M, Zhou B, et al. Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China. Eur J Clin Microbiol Infect Dis ESCMID. 2011;30(4):581–6.

Article  CAS  Google Scholar 

Timire C, Metcalfe JZ, Chirenda J, Scholten JN, Manyame-Murwira B, Ngwenya M, et al. Prevalence of drug-resistant tuberculosis in Zimbabwe: a health facility-based cross-sectional survey. IJID. 2019;87:119–25.

CAS  PubMed  Google Scholar 

Ahmad N, Javaid A, Sulaiman SA, Ming LC, Ahmad I, Khan AH. Resistance patterns, prevalence, and predictors of fluoroquinolones resistance in multidrug resistant tuberculosis patients. Braz J Infect Dis SBI. 2016;20(1):41–7.

Article  Google Scholar 

Mohammed KAS, Khudhair GS, Bekheet A-R. Prevalence and drug resistance pattern of Mycobacterium tuberculosis isolated from tuberculosis patients in Basra, Iraq. Pol J Microbiol. 2022;71(2):205–15.

Article  PubMed  PubMed Central  Google Scholar 

Hu Y, Mathema B, Zhao Q, Chen L, Lu W, Wang W, et al. Acquisition of second-line drug resistance and extensive drug resistance during recent transmission of Mycobacterium tuberculosis in rural China. Clin Microbiol Infect ESCMID. 2015;21(12):1093.

Google Scholar 

Mazahir R, Beig FK, Ahmed Z, Alam S. Burden of tuberculosis among household children of adult multi drug resistant patients and their response to first line anti tubercular drugs. Egypt Pediatr Assoc Gazette. 2017;65(4):122–6.

Article  Google Scholar 

Ayaz A, Hasan Z, Jafri S, Inayat R, Mangi R, Channa AA, et al. Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes. IJID. 2012;16(4):e303–9.

CAS  PubMed  Google Scholar 

Al-Dabbagh M, Lapphra K, McGloin R, Inrig K, Schaaf HS, Marais BJ, et al. Drug-resistant tuberculosis: pediatric guidelines. PIDJ. 2011;30(6):501–5.

Google Scholar 

Yang Y, Zhou C, Shi L, Meng H, Yan H. Prevalence and characterization of drug-resistant tuberculosis in a local hospital of Northeast China. IJID. 2014;22:83–6.

PubMed  Google Scholar 

Magula NP, Madala ND, Kriel Y, Bayi V, Duze NP, Manzini TC, et al. Prevalence of drug resistant tuberculosis in patients presenting with a large pericardial effusion at King Edward VIII Hospital. IJID. 2014;21:87.

Google Scholar 

Mahabeer P, Khan M, Mlisana K. Drug-resistant tuberculosis in children less than 5 years old with culture positive mycobacterium tuberculosis. IJID. 2016;45:212–3.

Google Scholar 

Berberian G, Gonzalez S, Reijtman V, Miño N, Casimir L, Sarkis C, et al. Seventeen years of drug-resistant tuberculosis in Argentinian children. IJID. 2016;45:387.

Google Scholar 

Singhal R, Arora J, Sah GC, Bhalla M, Sarin R, Prasad MV. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India. J Epidemiol Glob Health. 2017;7(3):175–80.

Article  PubMed  PubMed Central  Google Scholar 

Prakash R, Kumar D, Gupta VK, Jain S, Chauhan DS, Tiwari PK, et al. Status of multidrug resistant tuberculosis (MDR-TB) among the Sahariya tribe of North Central India. J Infect Public Health. 2016;9(3):289–97.

Article  PubMed  Google Scholar 

Dujaili JA, Blebil AQ, Dujaili MA, Awaisu A, Hassali MA, Syed Sulaiman SA. Prevelance of pulmonary tuberculosis and multi drug resistant tuberculosis patients in baghdad, Iraq. Value Health. 2013;16(3):A82.

Article  Google Scholar 

Santos LC, Bousquet Hde M, Pereira AM, Junqueira-Kipnis AP, Kipnis A. A high prevalence of resistance in new tuberculosis cases of midwestern Brazil. Infect Genet Evol. 2010;10(7):1052–7.

Article  PubMed  Google Scholar 

Kontsevaya I, Nikolayevskyy V, Kovalyov A, Ignatyeva O, Sadykhova A, Simak T, et al. Tuberculosis cases caused by heterogeneous infection in Eastern Europe and their influence on outcomes. Infect Genet Evol. 2017;48:76–82.

Article  PubMed  Google Scholar 

Bhembe NL, Green E. Molecular epidemiological study of multidrug-resistant tuberculosis isolated from sputum samples in Eastern Cape, South Africa. Infect Genet Evol. 2020;80: 104182.

Article  CAS  PubMed  Google Scholar 

Ghebremichael S, Petersson R, Koivula T, Pennhag A, Romanus V, Berggren I, et al. Molecular epidemiology of drug-resistant tuberculosis in Sweden. Microbes Infect. 2008;10(6):699–705.

Article  CAS  PubMed  Google Scholar 

Montoro E, Lemus D, Echemendía M, Armas L, González-Ochoa E, Llanes MJ, et al. Drug-resistant tuberculosis in Cuba results of the three global projects. Tuberculosis. 2006;86(3–4):319–23.

Article  PubMed  Google Scholar 

Pardini M, Niemann S, Varaine F, Iona E, Meacci F, Orrù G, et al. Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe. Tuberculosis. 2009;89(4):317–24.

Article  CAS  PubMed  Google Scholar 

Jiao W-W, Liu Z-G, Han R, Zhao X-Q, Dong F, Dong H-Y, et al. Prevalence of drug resistant Mycobacterium tuberculosis among children in China. Tuberculosis. 2015;95(3):315–20.

Article  PubMed  Google Scholar 

Brandao AP, Pinhata JMW, Simonsen V, Oliveira RS, Ghisi KT, Rabello MCS, et al. Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting. Tuberculosis. 2020;125: 102004.

Article  CAS  PubMed  Google Scholar 

Van Rie A, Warren R, Richardson M, Gie RP, Enarson DA, Beyers N, et al. Classification of drug-resistant tuberculosis in an epidemic area. Lancet. 2000;356(9223):22–5.

Article  PubMed  Google Scholar 

Chand K, Tewari S, Varghese S. Prevalence of drug resistant tuberculosis in armed forces-study from a tertiary referral chest diseases hospital at Pune. MJAFI. 2000;56(2):130–4.

Google Scholar 

Ismail NA, Mvusi L, Nanoo A, Dreyer A, Omar SV, Babatunde S, et al. Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey. Lancet Infect Dis. 2018;18(7):779–87.

Article  PubMed  PubMed Central  Google Scholar 

Daniel O, Osman E. Prevalence and risk factors associated with drug resistant TB in South West, Nigeria. Asian Pac J Trop Med. 2011;4(2):148–51.

Article  PubMed  Google Scholar 

Wang G, Peng YL, Zhang G, Zhang L, Xing J, Li D, et al. Sample survey of drug-resistant tuberculosis in Henan, China, 1996. Respirology. 2002;7(1):67–72.

Article  PubMed  Google Scholar 

Hannan MM, Peres H, Maltez F, Hayward AC, Machado J, Morgado A, et al. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect. 2001;47(2):91–7.

Article  CAS  PubMed  Google Scholar 

Wu B, Zhang L, Liu Z, He H, Pan A, Wang F, et al. Drug-resistant tuberculosis in Zhejiang Province, China: an updated analysis of time trends, 1999–2013. Glob Health Action. 2017;10(1):1293925.

Article  PubMed  PubMed Central  Google Scholar 

Phyu S, Lwin T, Ti T, Maung W, Mar WW, Shein SS, et al. Drug-resistant tuberculosis in Yangon, Myanmar. Scand J Infect Dis. 2005;37(11–12):846–51.

Article  PubMed  Google Scholar 

Hu Y, Mathema B, Wang W, Hoffner S, Kreiswirth B, Xu B. Prevalence of multidrug-resistant pulmonary tuberculosis in counties with different duration of DOTS implementation in rural China. Microb Drug Resist. 2008;14(3):227–32.

Article  CAS  PubMed  Google Scholar 

Shah MA, Shah I. Increasing prevalence of pediatric drug-resistant tuberculosis in Mumbai, India, and its outcome. PIDJ. 2018;37(12):1261–3.

Google Scholar 

Ignatova A, Dubiley S, Stepanshina V, Shemyakin I. Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Med Microbiol. 2006;55(10):1413–8.

Article  PubMed  Google Scholar